Clinical trial
Korea Post-Marketing Surveillance of Invega Sustenna
NCT01819818 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Korea Post-Marketing Surveillance of Invega Sustenna
- Lead sponsor
- Janssen Korea, Ltd., Korea
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 23, 2011
- Completion date
- November 29, 2019
- Enrollment
- 3,267 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.